1,175 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
AGN Allergan plc. $204.65 $68.42B Buy
Article Searches
Wall Street Breakfast: Economists Foresee Bumper GDP https://seekingalpha.com/article/4191072-wall-street-breakfast-economists-foresee-bumper-gdp?source=feed_tag_wall_st_breakfast Jul 27, 2018 -
Trump/Juncker In Trade Talks (Wall Street Breakfast Podcast) https://seekingalpha.com/article/4189796-trump-juncker-trade-talks-wall-street-breakfast-podcast?source=feed_all_articles Jul 25, 2018 - Today's top stories: Trump/Juncker in trade talks; EU reciprocal tariff threat; and Sergio Marchionne passes away. If you are interested in listening to Wall Street Breakfast to start your day, look f
Wall Street Breakfast: Key Talks On U.S.-EU Trade https://seekingalpha.com/article/4189776-wall-street-breakfast-key-talks-u-s-eu-trade?source=feed_tag_wall_st_breakfast Jul 25, 2018 - Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on iTunes, Stitcher and SoundCloud (click the highlighted links). President Trump will sit down with European
Drug Stocks to Report Earnings on Jul 26: AMGN, ALXN & More http://www.zacks.com/stock/news/313285/drug-stocks-to-report-earnings-on-jul-26-amgn-alxn-more?cid=CS-ZC-FT-313285 Jul 25, 2018 - Let's see how these five pharma/biotech stocks are poised ahead of their scheduled results on Jul 26.
Allergan's Depression Candidate Gets Fast Track Designation http://www.zacks.com/stock/news/313065/allergans-depression-candidate-gets-fast-track-designation?cid=CS-ZC-FT-313065 Jul 24, 2018 - The FDA grants fast track designation to Allergan's (AGN) AGN-241751, developed for the treatment of patients with major depressive disorder.
4 Members Of The $800+ Billion Market Cap Club https://seekingalpha.com/article/4189374-4-members-800-plus-billion-market-cap-club?source=feed_all_articles Jul 24, 2018 - Below is an updated look at the 35 largest S&P 500 companies. It's worth noting that recent gains have put four companies into the $800+ billion market cap club. Apple (NASDAQ:AAPL) is still on to
Applied Genetic Technologies Corporation: Near-Term Run Up Expected https://seekingalpha.com/article/4189316-applied-genetic-technologies-corporation-near-term-run-expected?source=feed_sector_healthcare Jul 23, 2018 - Shares are trading at roughly a third of the original IPO price. Recent accumulation is indicative of further upside in the near term. Pessimism and past setbacks have led to an incredibly cheap valua
Chickasaw Capital Management Llc Buys Williams Inc, Buckeye Partners LP, Renasant Corp, Sells ... http://www.gurufocus.com/news/711270/chickasaw-capital-management-llc-buys-williams-inc-buckeye-partners-lp-renasant-corp-sells-alerian-mlp-genuine-parts-co-oaktree-capital-group-llc Jul 23, 2018 - Chickasaw Capital Management Llc Buys Williams Inc, Buckeye Partners LP, Renasant Corp, Sells Alerian MLP, Genuine Parts Co, Oaktree Capital Group LLC, Stocks: WMB,BPL,AGN,ENB,PFE,FB,LLY,RNST,FLR,MAA,AMLP,TDOC,, release date:Jul 23, 2018
Allergan's AGN-241751 Fast Track'd in U.S. for MDD https://seekingalpha.com/news/3372325-allergans-agnminus-241751-fast-trackd-u-s-mdd?source=feed_news_all Jul 23, 2018 - The FDA designates Allergan's (NYSE:AGN) Phase 2-stage AGN-241751 for Fast Track review for the treatment of major depressive disorder (MDD).The company acquired the NMDAR modulator from Aptin
Allergan (AGN) to Report Q2 Earnings: What's in the Cards? http://www.zacks.com/stock/news/312762/allergan-agn-to-report-q2-earnings-whats-in-the-cards?cid=CS-ZC-FT-312762 Jul 23, 2018 - While Allergan's (AGN) Q2 sales are likely to be driven by new as well as established products like Botox and international growth, generic competition for some key products is expected to hurt sales.

Pages: 1234567...118

<Page 2>